Reference health

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

https://doi.org/10.1136/ard.2010.140145
CiteStamped reference-health badge
90/90 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

5 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 90 checked references that resolve
resolves10.1172/JCI31537
A cytokine-mediated link between innate immunity, inflammation, and cancer
resolves10.1038/nature07205
Cancer-related inflammation
resolves10.1038/nature01322
Inflammation and cancer
resolves10.1016/j.cell.2010.01.025
Immunity, Inflammation, and Cancer
resolves10.1038/nri1703
NF-κB: linking inflammation and immunity to cancer development and progression
resolves10.1016/j.gde.2009.11.004
Inflammation and oncogenesis: a vicious connection
resolves10.1038/nrc2734
STATs in cancer inflammation and immunity: a leading role for STAT3
resolves10.1038/nature04870
Nuclear factor-κB in cancer development and progression
resolves10.1038/10552
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
resolves10.1016/S1359-6101(01)00020-X
Tumor necrosis factor or tumor promoting factor?
resolves10.1038/nrc2628
Tumour necrosis factor and cancer
resolves10.1016/S0092-8674(00)81959-5
Stat3 as an Oncogene
resolves10.1016/j.cytogfr.2009.11.005
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
resolves10.1158/1078-0432.CCR-08-0149
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
resolves10.1038/embor.2009.243
IKK/NF‐κB and STAT3 pathways: central signalling hubs in inflammation‐mediated tumour promotion and metastasis
resolves10.1158/0008-5472.CAN-07-2924
Circulating Levels of Inflammatory Cytokines and Risk of Colorectal Adenomas
resolves10.1016/j.ccr.2007.12.020
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
resolves10.2174/187152808785748137
Cytokines in Colitis-Associated Cancer: Potential Drug Targets?
resolves10.1016/j.molmed.2007.12.007
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
resolves10.1016/j.cell.2004.07.013
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
resolves10.1016/j.ccr.2009.01.002
gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
resolves10.1016/j.ccr.2009.01.001
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
resolves10.1158/0008-5472.CAN-07-2735
Mouse Model of Colonic Adenoma-Carcinoma Progression Based on Somatic <i>Apc</i> Inactivation
resolves10.1126/science.1140485
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
resolves10.1016/j.immuni.2004.07.020
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
resolves10.4049/jimmunol.0801217
Essential Roles of IL-6 <i>Trans</i> -Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble–IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model
resolves10.1053/j.gastro.2008.12.003
The Interleukin-6 Family Cytokine Interleukin-11 Regulates Homeostatic Epithelial Cell Turnover and Promotes Gastric Tumor Development
resolves10.1038/sj.onc.1210286
Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon
resolves10.4161/cc.4.2.1413
IL-6 Signaling Promotes Tumor Growth in Colorectal Cancer
resolves10.1007/s10549-006-9328-3
Significance of interleukin-6 (IL-6) in breast cancer (review)
resolves10.1016/j.ccr.2009.01.009
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
resolves10.1053/j.gastro.2010.01.058
Inflammation and Colon Cancer
resolves10.1074/jbc.M210584200
Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)
resolves10.1089/jir.2005.25.241
<i>Review:</i> IL-6 Transsignaling: The <i>In Vivo</i> Consequences
resolves10.1038/clpt.2010.1
Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
resolves10.4049/jimmunol.159.3.1474
Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice
resolves10.2174/138161209788489140
Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease
resolves10.1136/gut.2009.184176
Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
resolves10.1084/jem.20082683
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
resolves10.1186/1747-1028-5-14
Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
resolves10.1084/jem.20092366
Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice
resolves10.1053/j.gastro.2010.04.043
Loss of Single Immunoglobulin Interlukin-1 Receptor-Related Molecule Leads to Enhanced Colonic Polyposis in Apcmin Mice
resolves10.1038/nm.2143
ERK activation drives intestinal tumorigenesis in Apcmin/+ mice
resolves10.1093/carcin/bgl018
Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc ( Min/+ ) colon epithelial cell line
resolves10.1093/carcin/bgm180
Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma
resolves10.1084/jem.193.4.471
Cis3/Socs3/Ssi3 Plays a Negative Regulatory Role in Stat3 Activation and Intestinal Inflammation
resolves10.1038/75068
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
resolves10.1111/j.1572-0241.1999.01288.x
Clinical Relevance of Serum Interleukin-6 in Crohn's Disease: Single Point Measurements, Therapy Monitoring, and Prediction of Clinical Relapse
resolves10.1385/CRIAI:28:3:187
Involvement of IL-6 in the Pathogenesis of Inflammatory Bowel Disease and Colon Cancer
resolves10.1016/j.cytogfr.2006.09.003
Interleukin-6 trans-signaling in inflammatory bowel disease
resolves10.4049/jimmunol.179.4.2041
Cutting Edge: <i>Trans-</i> Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25− T Cells
resolves10.1038/nm.2015
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses
resolves10.1007/s00281-009-0161-8
Colitis-associated cancer: the role of T cells in tumor development
resolves10.1158/0008-5472.CAN-04-3104
CD4+CD25+ Regulatory Lymphocytes Induce Regression of Intestinal Tumors in <i>ApcMin/+</i> Mice
resolves10.1016/S1074-7613(00)80334-9
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
resolves10.4049/jimmunol.181.3.2189
IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT3
resolves10.1111/j.1365-3083.2006.01750.x
Interleukin‐6 Trans‐Signalling in Chronic Inflammation and Cancer
resolves10.1016/j.immuni.2010.05.010
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
resolves10.1016/j.coi.2010.01.021
Myeloid-derived suppressor cell heterogeneity and subset definition
resolves10.1038/nri2506
Myeloid-derived suppressor cells as regulators of the immune system
resolves10.1016/j.cytogfr.2008.04.010
Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: Mouse models
resolves10.1016/S1359-6101(02)00019-9
Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments
resolves10.1146/annurev-immunol-082708-100732
Translating Molecular Insights in Autoimmunity into Effective Therapy
resolves10.1016/j.coph.2007.06.001
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases
resolves10.1158/0008-5472.CAN-08-1565
Low Levels of Tumor Necrosis Factor α Increase Tumor Growth by Inducing an Endothelial Phenotype of Monocytes Recruited to the Tumor Site
resolves10.1002/iub.309
Tumor necrosis factor, lymphotoxin and cancer
resolves10.1016/S0074-7696(06)52002-9
Intracellular Signals and Events Activated by Cytokines of the Tumor Necrosis Factor Superfamily: From Simple Paradigms to Complex Mechanisms
resolves10.2174/156800907780809723
AP-1 a Target for Cancer Prevention
resolves10.1038/nri2784
Unravelling mononuclear phagocyte heterogeneity
resolves10.1126/science.1178331
Development of Monocytes, Macrophages, and Dendritic Cells
resolves10.1016/j.ccr.2009.07.015
Colitis-Associated Colorectal Cancer Driven by T-bet Deficiency in Dendritic Cells
resolves10.1038/nature02924
NF-κB functions as a tumour promoter in inflammation-associated cancer
resolves10.1172/JCI39065
The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
resolves10.1074/jbc.M801269200
TNFR1 Promotes Tumor Necrosis Factor-mediated Mouse Colon Epithelial Cell Survival through RAF Activation of NF-κB
resolves10.1073/pnas.0801463105
Transactivation of EGF receptor and ErbB2 protects intestinal epithelial cells from TNF-induced apoptosis
resolves10.1152/ajpgi.00071.2008
Signaling pathway via TNF-α/NF-κB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis
resolves10.1016/j.immuni.2010.02.012
Control of Intestinal Homeostasis, Colitis, and Colitis-Associated Colorectal Cancer by the Inflammatory Caspases
resolves10.1084/jem.20100050
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
resolves10.1016/j.cell.2004.07.002
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
resolves10.1084/jem.20100199
MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
resolves10.1002/ijc.24281
High serum interleukin‐6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
resolves10.1016/j.cell.2005.04.014
IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis
resolves10.1016/j.ccr.2006.12.016
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
resolves10.1101/cshperspect.a000141
NF- B as a Critical Link Between Inflammation and Cancer
resolves10.1016/j.ccr.2008.06.016
Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis
resolves10.1016/j.ccr.2009.12.048
Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
resolves10.1146/annurev.med.51.1.245
Age-Associated Increased Interleukin-6 Gene Expression, Late-Life Diseases, and Frailty
resolves10.1053/j.gastro.2004.09.011
Primary liver cancer: Worldwide incidence and trends
resolves10.1016/j.cell.2009.12.052
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
resolves10.1016/j.ccr.2009.08.021
A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma
The 5 references without a DOI — listed, not checked
no DOI — not checkedSTAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice
no DOI — not checkedModeling the function of tumor necrosis factor in immune pathophysiology
no DOI — not checkedDistinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects
no DOI — not checkedBlocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis
no DOI — not checkedMice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1136/ard.2010.140145"><img src="https://citestamp.com/citestamped/10.1136/ard.2010.140145/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1136/ard.2010.140145/badge.svg)](https://citestamp.com/citestamped/10.1136/ard.2010.140145)